Nucleic Acid Nanoparticles (NANPs): A New Dawn for Immunotherapy and Vaccines
Dr. Kirill Afonin's team found that building DNA aptamers into fibrous nucleic acid nanoparticles can tune down the immune response the particles trigger in cells.
Featured institute
University of North Carolina at Charlotte
Features on peer-reviewed research by scientists at University of North Carolina at Charlotte.